￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The fastest resistance time to lorlatinib/lorlatinib

2026-02-01 22:25:32

Check Details
Lorlatinib/lorlatinib’s domestic launch time and its significance in the treatment of lung cancer

2026-02-01 22:25:32

Check Details
Discussion on the monthly treatment cost of lorlatinib/lorlatinib

2026-02-01 22:25:32

Check Details
Lorlatinib/Lorlatinib: Functional Analysis and Main Therapeutic Areas

2026-02-01 22:25:32

Check Details
Which patients is obeticholic acid suitable for? What should patients pay attention to when taking medication?

2026-02-01 22:25:32

Check Details
Beacon version obeticholic acid price and purchasing guide

2026-02-01 22:25:32

Check Details
The latest information on the domestic launch progress and market price of obeticholic acid in 2024

2026-02-01 22:25:32

Check Details
Brief description of ibrutinib/ibrutinib medication guidelines

2026-02-01 22:25:32

Check Details
Detailed explanation of the usage and precautions of Incepta version of ibrutinib/ibrutinib

2026-02-01 22:25:32

Check Details
What are the serious side effects that may occur when taking ibrutinib/ibrutinib, and are they likely to occur?

2026-02-01 22:25:32

Check Details
What to do after cabozantinib resistance?

2026-02-01 22:25:32

Check Details
Analysis of the main role of cabozantinib as a targeted drug

2026-02-01 22:25:32

Check Details
Category
相关知识